BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12209724)

  • 1. Cyclooxygenase-2 expression in endometrial carcinoma: correlation with clinicopathologic parameters and clinical outcome.
    Ferrandina G; Legge F; Ranelletti FO; Zannoni GF; Maggiano N; Evangelisti A; Mancuso S; Scambia G; Lauriola L
    Cancer; 2002 Aug; 95(4):801-7. PubMed ID: 12209724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma.
    Denkert C; Winzer KJ; Müller BM; Weichert W; Pest S; Köbel M; Kristiansen G; Reles A; Siegert A; Guski H; Hauptmann S
    Cancer; 2003 Jun; 97(12):2978-87. PubMed ID: 12784332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2 and p53 expressions in endometrial cancer.
    Jeon YT; Kang S; Kang DH; Yoo KY; Park IA; Bang YJ; Kim JW; Park NH; Kang SB; Lee HP; Song YS
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1538-42. PubMed ID: 15342458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer.
    Ferrandina G; Ranelletti FO; Gallotta V; Martinelli E; Zannoni GF; Gessi M; Scambia G
    Gynecol Oncol; 2005 Sep; 98(3):383-9. PubMed ID: 15979129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy.
    Kim YB; Kim GE; Cho NH; Pyo HR; Shim SJ; Chang SK; Park HC; Suh CO; Park TK; Kim BS
    Cancer; 2002 Aug; 95(3):531-9. PubMed ID: 12209745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
    Kim YB; Kim GE; Pyo HR; Cho NH; Keum KC; Lee CG; Seong J; Suh CO; Park TK
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):822-9. PubMed ID: 15465199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic and prognostic significance of cyclooxygenase-2 expression in endometrial carcinoma.
    Lambropoulou M; Alexiadis G; Limberis V; Nikolettos N; Tripsianis G
    Histol Histopathol; 2005 Jul; 20(3):753-9. PubMed ID: 15944924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium.
    Orejuela FJ; Ramondetta LM; Smith J; Brown J; Lemos LB; Li Y; Hollier LM
    Gynecol Oncol; 2005 May; 97(2):483-8. PubMed ID: 15863148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cyclooxygenase-2 (COX-2) in non-neoplastic and neoplastic vulvar epithelial lesions.
    Ferrandina G; Ranelletti FO; Salutari V; Gessi M; Legge F; Zannoni GF; Scambia G; Lauriola L
    Gynecol Oncol; 2004 Feb; 92(2):537-44. PubMed ID: 14766245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
    Giordano G; Gnetti L; Merisio C; Melpignano M
    Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications].
    Wülfing C; Eltze E; Von Struensee D; Wülfing P; Bode ME; Bettendorf O; Piechota H; Hertle L
    Aktuelle Urol; 2004 Aug; 35(4):331-8. PubMed ID: 15459875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COX-2 and survivin are overexpressed and positively correlated in endometrial carcinoma.
    Erkanli S; Bolat F; Kayaselcuk F; Demirhan B; Kuscu E
    Gynecol Oncol; 2007 Feb; 104(2):320-5. PubMed ID: 17030351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexpression of cyclooxygenase-2 and thymidine phosphorylase as a prognostic indicator in patients with FIGO stage IIB squamous cell carcinoma of uterine cervix treated with radiotherapy and concurrent chemotherapy.
    Pyo H; Kim YB; Cho NH; Suh CO; Park TK; Yun YS; Kim GE
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):725-32. PubMed ID: 15936552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 expression in lymph node metastasis of cervical and vulvar cancer.
    Ferrandina G; Ranelletti FO; Lauriola L; Zannoni GF; Legge F; Gessi M; Salutari V; Scambia G
    Oncol Rep; 2003; 10(6):1799-804. PubMed ID: 14534699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder.
    Shariat SF; Matsumoto K; Kim J; Ayala GE; Zhou JH; Jian W; Benedict WF; Lerner S
    J Urol; 2003 Sep; 170(3):985-9. PubMed ID: 12913755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of COX-2 expression in human renal cell carcinoma.
    Tuna B; Yorukoglu K; Gurel D; Mungan U; Kirkali Z
    Urology; 2004 Dec; 64(6):1116-20. PubMed ID: 15596182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of matriptase and clinical outcome of human endometrial cancer.
    Nakamura K; Hongo A; Kodama J; Abarzua F; Nasu Y; Kumon H; Hiramatsu Y
    Anticancer Res; 2009 May; 29(5):1685-90. PubMed ID: 19443387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
    Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
    Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and in vitro studies.
    Chen WC; McBride WH; Chen SM; Lee KF; Hwang TZ; Jung SM; Shau H; Liao SK; Hong JH; Chen MF
    Head Neck; 2005 Jun; 27(6):503-12. PubMed ID: 15772955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival.
    Miyata Y; Koga S; Kanda S; Nishikido M; Hayashi T; Kanetake H
    Clin Cancer Res; 2003 May; 9(5):1741-9. PubMed ID: 12738729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.